Platelet response as the basis for approval in chronic immune (idiopathic) thrombocytopenic purpura (ITP): a regulatory perspective

MeSH terms

• Benzoates / therapeutic use*
• Clinical Trials as Topic / statistics & numerical data*
• Hemorrhage / prevention & control*
• Humans
• Hydrazines / therapeutic use*
• Purpura, Thrombocytopenic, Idiopathic / drug therapy*
• Pyrazoles / therapeutic use*
• Randomized Controlled Trials as Topic / statistics & numerical data*
• Receptors, Fc / therapeutic use*
• Recombinant Fusion Proteins / therapeutic use*
• Thrombopoietin / agonists*
• Thrombopoietin / therapeutic use